Blocking gephyrin phosphorylation or microglia BDNF signaling prevents synapse loss and reduces infarct volume after ischemia
Authors:
- Teresa CramerTCTeresa Cramer
- Raminder GillRGRaminder Gill
- Zahra S ThirouinZTZahra S Thirouin
- Markus VaasMVMarkus Vaas
- Suchita SampathSSSuchita Sampath
- Fanny MartineauFMFanny Martineau
- Sara B. NoyaSNSara B. Noya
- David ColameoDCDavid Colameo
- Philip K.-Y. ChangPCPhilip K.-Y. Chang
- Peiyou WuPWPeiyou Wu
- Philip A BarkerPBPhilip A Barker
- Steven A. BrownSBSteven A. Brown
Preprint
Abstract
Microglia interact with neurons to facilitate synapse plasticity; however, signal transducers between microglia and neuron remain unknown. Here, using in vitro organotypic hippocampal slice cultures and transient MCAO in genetically-engineered mice in vivo , we report that at 24 h post-ischemia microglia release BDNF to downregulate glutamatergic and GABAergic synapses within the peri-infarct area. Analysis of the CA1 hippocampal formation in vitro shows that proBDNF and mBDNF downregulate glutamatergic dendritic spines and gephyrin scaffold stability through p75 NTR and TrkB receptors respectively. Post-MCAO, we report that in the peri- infarct area and in the corresponding contralateral hemisphere similar neuroplasticity occur through microglia activation and gephyrin phosphorylation at Ser268, Ser270 in vivo . Targeted deletion of the Bdnf gene in microglia or Gphn S268A/S270A (phospho-null) point-mutations protect against ischemic brain damage, neuroinflamation and synapse downregulation normally seen post-MCAO. Collectively, we report that gephyrin phosphorylation and microglia derived BDNF faciliate synapse plasticity after transient ischemia.Keywords
All Related Versions
- Published version: Science Advances, 8 (9), eabj0112.
This publication has 80 references indexed in Scilit:
- Ischaemic strokeNature Reviews Disease Primers, 2019
- Stroke in theCentury: A Snapshot of the Burden, Epidemiology, and Quality of LifeStroke Research and Treatment, 2018
- A systematic review of clinical trials of pharmacological interventions for acute ischaemic stroke (1955-2008) that were completed, but not published in fullTrials, 2010
- Inflammatory mechanisms in ischemic stroke: therapeutic approachesJournal of Translational Medicine, 2009
- The complexity of neurobiological processes in acute ischemic strokeClinical Neurology and Neurosurgery, 2009
- NXY-059 for the Treatment of Acute Ischemic StrokeNew England Journal of Medicine, 2007
- Rapid Reversible Changes in Dendritic Spine StructureIn VivoGated by the Degree of IschemiaJournal of Neuroscience, 2005
- Aptiganel Hydrochloride in Acute Ischemic StrokeJAMA, 2001
- Synergistic Combinatorial Stroke Therapy: A Quantal Bioassay of a GABA Agonist and a Glutamate AntagonistExperimental Neurology, 2000
- Rapid Down‐Regulation of GABAA Receptors in the Gerbil Hippocampus Following Transient Cerebral IschemiaJournal of Neurochemistry, 1995